A simultaneous presentation of drug-induced lupus with drug-induced ANCA vasculitis secondary to hydralazine use in a patient with sarcoidosis.
Maria Catalina L EspinosaBelicia DingKati ChoiDaniel N CohenMarco MarcelliOnome Whiteru IfoezePublished in: Proceedings (Baylor University. Medical Center) (2019)
Frequently used in the management of hypertension and heart failure, hydralazine is associated with the development of adverse rheumatologic side effects. The authors highlight a unique case of drug-induced lupus and drug-induced anti-neutrophil cytoplasmic antibody (ANCA) vasculitis from hydralazine use in a 50-year-old man with sarcoidosis and hypertension.